RR No. 2-2023: Constructive Affixture of Documentary Stamps for Government-Issued Certificates and DST Proof of Payment

RR No. 2-2023 requires official receipt-based constructive affixture as DST proof for taxable government-issued certificates, with monthly BIR Form 2000 remittance. Government agencies and instrumentalities that issue taxable certificates must now use the constructive affixture system for Documentary Stamp Tax, replacing the loose documentary stamp approach with an official receipt-based proof of payment. For businesses […]

RMC No. 29-2023: Clarifying the Effect of Publication of Cannot Be Located (CBL) Taxpayers on Business Transactions and Compliance

RMC No. 29-2023 clarifies the effect of publishing Cannot Be Located (CBL) taxpayers, affecting deductions, prescriptive periods, and due diligence for businesses. Businesses and taxpayers must immediately understand the implications of being listed as Cannot Be Located (CBL) under RMC No. 29-2023. The publication of a taxpayer as CBL affects the deductibility of purchases, future […]

RMC No. 28-2023: BIR Guidance on Extended Producer Responsibility for Plastic Packaging Waste Under RA 11898

RMC No. 28-2023 alerts businesses that RA 11898 and its DENR IRR on EPR for plastic packaging waste are now circulated for BIR-wide guidance. Businesses that place products using plastic packaging waste in the Philippine market should now treat Extended Producer Responsibility compliance as a board-level regulatory issue, not merely an environmental matter. RMC No. […]

RMC No. 26-2023: Updated January 2023 List of Accredited Microfinance NGOs for BIR Compliance Checks

RMC No. 26-2023 circularizes the January 2023 list of accredited Microfinance NGOs and flags certificate validity, expiry, and revocation checks. Businesses, accountants, donors, counterparties, and tax teams dealing with microfinance non-government organizations should immediately verify whether the organization they are transacting with appears in the updated January 2023 list of accredited Microfinance NGOs, because accreditation […]

RMC No. 23-2023: Updated Classification and Processing Times for One-Time BIR Transactions

RMC No. 23-2023 revises classification and processing times for One-Time Transactions, setting clear timelines for OCS and eCAR issuance for real property, stocks, donations, and estates. Businesses and taxpayers must adjust their expectations and planning for One-Time Transactions (ONETT) at the BIR, as processing times for the issuance of ONETT Computation Sheets (OCS) and Electronic […]

RMC No. 14-2023: Immediate Action Required for Lost BIR Form 0535 Sets and Invalid Transactions

RMC No. 14-2023 reports the loss of six sets of BIR Form 0535 (Taxpayer Information Sheet), invalidating any transactions using these sets. Immediate precautions are required. Businesses and tax practitioners must be aware that six sets of BIR Form No. 0535 โ€“ Taxpayer Information Sheet (TIS) have been reported lost, rendering any transactions using these […]

RMC No. 150-2022: Streamlined Access to SRA Sugar Production Bulletins for Withholding Tax Compliance

RMC No. 150-2022 requires sugar stakeholders to use SRA-issued weekly bulletins for computing 1% CWT on millsite withdrawals, accessible via the BIR website. Businesses that handle sugar withdrawals from mills must now rely on the Sugar Regulatory Administration’s (SRA) weekly bulletins for computing the 1% Creditable Withholding Tax (CWT) under Revenue Regulations No. 13-2015. RMC […]

RMC No. 148-2022: BIR Field Audits, Business Visitations, LOAs, Audit Notices, and Mission Orders Resume Immediately

RMC No. 148-2022 immediately resumes BIR field audits, business visitations, LOAs, Audit Notices, and Mission Orders for taxpayers. Businesses should immediately prepare for the resumption of BIR field audits, field operations, business visitations, and the implementation of Letters of Authority, Audit Notices, and Mission Orders because RMC No. 148-2022 lifted the prior suspension effective immediately […]

RMC No. 119-2022: VAT Exemption for Newly Endorsed COVID-19 Medicines

RMC No. 119-2022 adds Nirmatrelvir + Ritonavir 150 mg + 100 mg tablets for COVID-19 to the VAT-exempt list, effective from FDA publication, impacting healthcare providers and distributors. Businesses and healthcare providers must update their VAT-exempt inventory immediately: the Food and Drug Administration has added Nirmatrelvir + Ritonavir 150 mg + 100 mg film-coated tablets […]

RMC No. 113-2022: Updates to VAT-Exempt Medicines under the CREATE Act Affecting COVID-19 Treatments

RMC No. 113-2022 updates the VAT-exempt medicines list under the CREATE Act, correcting and deleting certain COVID-19 treatments, effective July 1, 2022. Businesses must adjust VAT filings accordingly. Businesses dealing with pharmaceutical sales must immediately review their VAT compliance for medicines prescribed for COVID-19. Recent updates endorsed by the Food and Drug Administration now correct […]